Single cell tracking reveals that Msh2 is a key component of an early-acting DNA damage-activated G2 checkpoint

Oncogene

Volumn 22, Issue 48, 2003, Pages 7642-7648

  Marquez, Nuria ^a   Chappell, Sally C ^a   Sansom, Owen J ^b   Clarke, Alan R ^b   Court, Jon ^c   Errington, Rachel J ^a   Smith, Paul J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c Velindre NHS Trust   (United Kingdom)

Author keywords

Event analysis; G2 checkpoint; Mouse embryonic fibroblasts; Msh2; Time lapse microscopy

Indexed keywords

CISPLATIN; DNA MISMATCH REPAIR PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL DEATH; CELL KINETICS; CELL SUBPOPULATION; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; EMBRYO; FIBROBLAST; GENE FUNCTION; MICROSCOPY; MISMATCH REPAIR; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; CISPLATIN; DNA DAMAGE; DNA-BINDING PROTEINS; FIBROBLASTS; G2 PHASE; MICE; MITOSIS; MUTS HOMOLOG 2 PROTEIN; PROTO-ONCOGENE PROTEINS; TIME FACTORS;

ANIMALIA;

EID: 0344010016     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206876     Document Type: Article

References (34)

1. Aebi S, Fink D, Gordon R, Kim HK, Zheng H, Fink VL and Howell SB. (1997). Clin. Cancer. Res., 3, 1763-1767.
2. Aquilina G, Crescenzi M and Bignami M. (1999). Carcinogenesis, 20, 2317-2326.
3. Bellacosa A. (2001). Cell Death Differ., 8, 1076-1092.
4. Branch P, Massson M, Aquilina G, Bignami M and Karran P. (2000). Oncogene, 19, 3138-3145.
5. Brown R, Hirst GL, Gallagher WM, Mcllwrath AJ, Margison GP, van der Zee AG and Anthoney DA. (1997). Oncogene, 15, 45-52.
6. Buermeyer AB, Deschenes SM, Baker SM and Liskay RM. (1999). Ann. Rev. Genet., 33, 533-564.
7. Christmann M and Kaina B. (2000). J. Biol. Chem., 275, 36256-36262.
8. Christmann M, Tomicic MT and Kaina B. (2002). Nucleic Acids Res., 30, 1959-1966.
9. de las Alas MM, Aebi S, Fink D, Howell SB and Los G. (1997). J. Natl. Cancer Inst., 89, 1537-1541.
10. Epstein RJ, Watson JV and Smith PJ. (1988). Cytometry, 9, 349-358.
11. Evans DL and Dive C. (1993). Cancer Res., 53, 2133-2139.
12. Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehré A, Christen RD and Howell SB. (1996). Cancer. Res., 56, 4881-4886.
13. Fink D, Aebi S and Howell SB. (1998). Clin. Cancer Res., 4, 1-6.
14. Fishel R, Lescoe MK, Rao MR, Copeland NF, Jenkings NA, Garber J, Kane M and Kolodner R. (1993). Cell, 75, 1027-1038.
15. Hartwell LH and Kastan MB. (1994). Science, 266, 1821-1828.
16. Hirose Y, Berger MS and Pieper RO. (2001). Cancer Res., 61, 1957-1963.
17. Karran P and Bignami M. (1999). DNA recombination and repair. Smith PJ, Jones CJ (eds). Oxford University Press: New York, pp. 66-98.
18. Kolodner RD. (1995). Trans. Biochem. Sci., 20, 397-401.
19. Kravtsov VD, Daniel TO and Koury MJ. (1999). Am. J. Pathol., 155, 1327-1339.
20. Lage H, Christmann M, Kern MA, Dietel M, Pick M, Kaina B and Schadendorf D. (1999). Int. J. Cancer, 80, 744-750.
21. Lin X, Ramamuthi K, Mishima M, Kondo A, Christen RD and Howell SB. (2001). Cancer Res., 15, 1508-1516.
22. Moreland NJ, Illand M, Kim YT, Paul J and Brown R. (1999). Cancer Res., 59, 2102-2106.
23. Nehme A, Baskaran R, Nebel S, Fink D, Howell SB, Wang JY and Christen RD. (1999). Br. J. Cancer, 79, 1104-1110.
24. Sansom OJ and Clarke AR. (2002). Oncogene, 21, 5934-5939.
25. Sansom OJ, Toft NJ, Winton J and Clark AR. (2001). Oncogene, 20, 3580-3584.
26. Sorenson CM and Eastman SA. (1988). Cancer Res., 48, 6703-6707.
27. Strathdee G, Sansom OJ, Sim A, Clarke AR and Brown R. (2001). Oncogene, 20, 1923-1927.
28. Therneau TM and Grambsch PM. (2000). Modeling Survival Data. Extending the Cox Model, Springer-Verlag: New York.
29. Toft NJ, Winton DJ, Kelly J, Howard LA, Dekker M, te Riele H, Arends MJ, Wyllie AH, Margison GP and Clarke AR. (1999). Proc. Natl. Acad Sci. USA, 96, 3911-3915.
30. Watson JV, Chambers SH and Smith PJ. (1987). Cytometry, 8, 1-8.
31. Xu B, Kim ST and Kastan MB. (2001). Mol. Cell. Biol., 21, 3445-3450.
32. Xu B, Kim ST, Lim DS and Kastan MB. (2002). Mol. Cell. Biol., 22, 1049-1059.
33. Yan T, Schupp JE, Hwang HS, Wagner MW, Berry SE, Strickfaden S, Veigl ML, Sedwick WD, Boothman DA and Kinsella TJ. (2001). Cancer Res., 61, 8290-8297.
34. Zindy F, Eishen CM, Randel DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF. (1998). Genes Dev., 12, 2424-2433.